Last update Oct. 17, 2016

Tamsulosin

Low Risk

Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

It is an alpha-1-adrenergic blocking agent that is used for treatment of benign prostate hypertrophy and troubles with urine voiding as obstruction or lithiasis.

At latest update, relevant published data on excretion into breast milk were not found.

Because of its pharmacokinetics (moderately high molecular weight and high protein-binding capacity) excretion into breast milk in significant amount is unlikely.

Alternatives

  • Oxybutynin (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
  • Tolterodine Tartrate (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Tamsulosin is also known as


Tamsulosin in other languages or writings:

Group

Tamsulosin belongs to this group or family:

Tradenames

Main tradenames from several countries containing Tamsulosin in its composition:

List of 17 tradenames

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 90 %
Molecular weight 445 daltons
Protein Binding 99 %
VD 0.2 l/Kg
Tmax 6 hours
T½ 10 - 13 hours

References

  1. Tamsulosina. Ficha técnica. 2014 Full text (in our servers)
  2. BI. Tamsulosin. Drug Summary. 2014 Full text (in our servers)

Total visits

32,152

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM